RMP-7 peptide analog and bradykinin agonist: ALKS began a multicenter Phase II trial

Alkermes Inc. (ALKS), Cambridge, Mass. Product: RMP-7 peptide analog and bradykinin agonist Indication: Brain cancer Status: ALKS began a multicenter Phase II trial of RMP-7 with carboplatin, which is...